Top

Published in:

Open Access 01-04-2018 | Original Article

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics

Authors: B. Hirsch, V. Endris, S. Lassmann, W. Weichert, N. Pfarr, P. Schirmacher, V. Kovaleva, M. Werner, I. Bonzheim, F. Fend, J. Sperveslage, K. Kaulich, A. Zacher, G. Reifenberger, K. Köhrer, S. Stepanow, S. Lerke, T. Mayr, D. E. Aust, G. Baretton, S. Weidner, A. Jung, T. Kirchner, M. L. Hansmann, L. Burbat, E. von der Wall, M. Dietel, M. Hummel

Published in: Virchows Archiv | Issue 4/2018

Abstract

The simultaneous detection of multiple somatic mutations in the context of molecular diagnostics of cancer is frequently performed by means of amplicon-based targeted next-generation sequencing (NGS). However, only few studies are available comparing multicenter testing of different NGS platforms and gene panels. Therefore, seven partner sites of the German Cancer Consortium (DKTK) performed a multicenter interlaboratory trial for targeted NGS using the same formalin-fixed, paraffin-embedded (FFPE) specimen of molecularly pre-characterized tumors (n = 15; each n = 5 cases of Breast, Lung, and Colon carcinoma) and a colorectal cancer cell line DNA dilution series. Detailed information regarding pre-characterized mutations was not disclosed to the partners. Commercially available and custom-designed cancer gene panels were used for library preparation and subsequent sequencing on several devices of two NGS different platforms. For every case, centrally extracted DNA and FFPE tissue sections for local processing were delivered to each partner site to be sequenced with the commercial gene panel and local bioinformatics. For cancer-specific panel-based sequencing, only centrally extracted DNA was analyzed at seven sequencing sites. Subsequently, local data were compiled and bioinformatics was performed centrally. We were able to demonstrate that all pre-characterized mutations were re-identified correctly, irrespective of NGS platform or gene panel used. However, locally processed FFPE tissue sections disclosed that the DNA extraction method can affect the detection of mutations with a trend in favor of magnetic bead-based DNA extraction methods. In conclusion, targeted NGS is a very robust method for simultaneous detection of various mutations in FFPE tissue specimens if certain pre-analytical conditions are carefully considered.

Available only for authorised users

Alioto TS, Buchhalter I, Derdak S, Hutter B, Eldridge MD, Hovig E, Heisler LE, Beck TA, Simpson JT, Tonon L, Sertier AS, Patch AM, Jager N, Ginsbach P, Drews R, Paramasivam N, Kabbe R, Chotewutmontri S, Diessl N, Previti C, Schmidt S, Brors B, Feuerbach L, Heinold M, Grobner S, Korshunov A, Tarpey PS, Butler AP, Hinton J, Jones D, Menzies A, Raine K, Shepherd R, Stebbings L, Teague JW, Ribeca P, Giner FC, Beltran S, Raineri E, Dabad M, Heath SC, Gut M, Denroche RE, Harding NJ, Yamaguchi TN, Fujimoto A, Nakagawa H, Quesada V, Valdes-Mas R, Nakken S, Vodak D, Bower L, Lynch AG, Anderson CL, Waddell N, Pearson JV, Grimmond SM, Peto M, Spellman P, He M, Kandoth C, Lee S, Zhang J, Letourneau L, Ma S, Seth S, Torrents D, Xi L, Wheeler DA, Lopez-Otin C, Campo E, Campbell PJ, Boutros PC, Puente XS, Gerhard DS, Pfister SM, McPherson JD, Hudson TJ, Schlesner M, Lichter P, Eils R, Jones DT, Gut IG (2015) A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nat Commun 6:10001. https://doi.org/10.1038/ncomms10001 CrossRefPubMedPubMedCentral

Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV (2015) College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Archives of pathology & laboratory medicine 139(4):481–493. https://doi.org/10.5858/arpa.2014-0250-CP CrossRef

Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR, Wooster R (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91(2):355–358. https://doi.org/10.1038/sj.bjc.6601894 CrossRefPubMedPubMedCentral

Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, Fernandez PL, Hofler G, Kothmaier H, Kruslin B, Mazzanti CM, Perren A, Popper H, Scarpa A, Soares P, Stanta G, Groenen PJ (2010) Multicentre validation study of nucleic acids extraction from FFPE tissues. Virchows Arch 457(3):309–317. https://doi.org/10.1007/s00428-010-0917-5 CrossRefPubMedPubMedCentral

Chen X, Shi X, Hilakivi-Clarke L, Shajahan-Haq AN, Clarke R, Xuan J (2017) PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification. Bioinformatics 33(2):177–183. https://doi.org/10.1093/bioinformatics/btw605 CrossRefPubMed

Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, Land SJ, Lu X, Ruden DM (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6(2):80–92. https://doi.org/10.4161/fly.19695 CrossRefPubMedPubMedCentral

Endris V, Stenzinger A, Pfarr N, Penzel R, Mobs M, Lenze D, Darb-Esfahani S, Hummel M, Sabine Merkelbach B, Jung A, Lehmann U, Kreipe H, Kirchner T, Buttner R, Jochum W, Hofler G, Dietel M, Weichert W, Schirmacher P (2016) NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial. Virchows Arch 468(6):697–705. https://doi.org/10.1007/s00428-016-1919-8 CrossRefPubMed

Fawcett GL, Karina Eterovic A (2017) Identification of genomic somatic variants in cancer: from discovery to actionability. Adv Clin Chem 78:123–162. https://doi.org/10.1016/bs.acc.2016.07.006 CrossRefPubMed

Fujita S, Masago K, Takeshita J, Okuda C, Otsuka K, Hata A, Kaji R, Katakami N, Hirata Y (2015) Validation of an ion torrent sequencing platform for the detection of gene mutations in biopsy specimens from patients with non-small-cell lung cancer. PLoS One 10(6):e0130219. https://doi.org/10.1371/journal.pone.0130219 CrossRefPubMedPubMedCentral

10.

Ghazani AA, Oliver NM, St Pierre JP, Garofalo A, Rainville IR, Hiller E, Treacy DJ, Rojas-Rudilla V, Wood S, Bair E, Parello M, Huang F, Giannakis M, Wilson FH, Stover EH, Corsello SM, Nguyen T, Rana HQ, Church AJ, Lowenstein C, Cibulskis C, Amin-Mansour A, Heng J, Brais L, Santos A, Bauer P, Waldron A, Lo P, Gorman M, Lydon CA, Welch M, McNamara P, Gabriel S, Sholl LM, Lindeman NI, Garber JE, Joffe S, Van Allen EM, Gray SW, Ja Nne PA, Garraway LA, Wagle N (2017) Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genet Med 19(7):787–795. https://doi.org/10.1038/gim.2016.191 CrossRefPubMed

11.

Hirotsu Y, Kojima Y, Okimoto K, Amemiya K, Mochizuki H, Omata M (2016) Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer. BMC Genomics 17(1):833. https://doi.org/10.1186/s12864-016-3166-4 CrossRefPubMedPubMedCentral

12.

Kovaleva V, Geissler AL, Lutz L, Fritsch R, Makowiec F, Wiesemann S, Hopt UT, Passlick B, Werner M, Lassmann S (2016) Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Mol Cancer 15(1):63. https://doi.org/10.1186/s12943-016-0549-8 CrossRefPubMedPubMedCentral

13.

Kriegsmann M, Endris V, Wolf T, Pfarr N, Stenzinger A, Loibl S, Denkert C, Schneeweiss A, Budczies J, Sinn P, Weichert W (2014) Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences. Oncotarget 5(20):9952–9965. https://doi.org/10.18632/oncotarget.2481 CrossRefPubMedPubMedCentral

14.

LaDuca H, Farwell KD, Vuong H, HM L, Mu W, Shahmirzadi L, Tang S, Chen J, Bhide S, Chao EC (2017) Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. PLoS One 12(2):e0170843. https://doi.org/10.1371/journal.pone.0170843 CrossRefPubMedPubMedCentral

15.

Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC (2014) Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123(14):2220–2228. https://doi.org/10.1182/blood-2013-11-537167 CrossRefPubMed

16.

Mendez P, Dang J, Kim JW, Lee S, Yoon JH, Kim T, Sailey CJ, Jablons DM, Kim IJ (2016) Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories. Int J Oncol 49:235–242. https://doi.org/10.3892/ijo.2016.3497 CrossRefPubMed

17.

Miao D, Van Allen EM (2016) Genomic determinants of cancer immunotherapy. Curr Opin Immunol 41:32–38. https://doi.org/10.1016/j.coi.2016.05.010 CrossRefPubMed

18.

Ojamies PN, Kontro M, Edgren H, Ellonen P, Lagstrom S, Almusa H, Miettinen T, Eldfors S, Tamborero D, Wennerberg K, Heckman C, Porkka K, Wolf M, Kallioniemi O (2016) Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia. Leukemia 31(5):1048–1058. https://doi.org/10.1038/leu.2016.286 CrossRefPubMed

19.

Paasinen-Sohns A, Koelzer VH, Frank A, Schafroth J, Gisler A, Sachs M, Graber A, Rothschild SI, Wicki A, Cathomas G, Mertz KD (2017) Single-center experience with a targeted next generation sequencing assay for assessment of relevant somatic alterations in solid tumors. Neoplasia 19(3):196–206. https://doi.org/10.1016/j.neo.2017.01.003 CrossRefPubMedPubMedCentral

20.

Raymond S, Nicot F, Jeanne N, Delfour O, Carcenac R, Lefebvre C, Cazabat M, Saune K, Delobel P, Izopet J (2017) Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use. Sci Rep 7:42215. https://doi.org/10.1038/srep42215 CrossRefPubMedPubMedCentral

21.

Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29(1):24–26. https://doi.org/10.1038/nbt.1754 CrossRefPubMedPubMedCentral

22.

Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, Leamon JH, Johnson K, Milgrew MJ, Edwards M, Hoon J, Simons JF, Marran D, Myers JW, Davidson JF, Branting A, Nobile JR, Puc BP, Light D, Clark TA, Huber M, Branciforte JT, Stoner IB, Cawley SE, Lyons M, Fu Y, Homer N, Sedova M, Miao X, Reed B, Sabina J, Feierstein E, Schorn M, Alanjary M, Dimalanta E, Dressman D, Kasinskas R, Sokolsky T, Fidanza JA, Namsaraev E, McKernan KJ, Williams A, Roth GT, Bustillo J (2011) An integrated semiconductor device enabling non-optical genome sequencing. Nature 475(7356):348–352. https://doi.org/10.1038/nature10242 CrossRefPubMed

23.

Shokralla S, Porter TM, Gibson JF, Dobosz R, Janzen DH, Hallwachs W, Golding GB, Hajibabaei M (2015) Massively parallel multiplex DNA sequencing for specimen identification using an Illumina MiSeq platform. Sci Rep 5(1):9687. https://doi.org/10.1038/srep09687 CrossRefPubMedPubMedCentral

24.

Sie D, Snijders PJ, Meijer GA, Doeleman MW, van Moorsel MI, van Essen HF, Eijk PP, Grunberg K, van Grieken NC, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DA (2014) Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology. Cell Oncol (Dordr) 37(5):353–361. https://doi.org/10.1007/s13402-014-0196-2 CrossRef

25.

Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT, Scarpa A (2013) DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One 8(6):e62692. https://doi.org/10.1371/journal.pone.0062692 CrossRefPubMedPubMedCentral

26.

Thorvaldsdottir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2):178–192. https://doi.org/10.1093/bib/bbs017 CrossRefPubMed

27.

Tops BB, Normanno N, Kurth H, Amato E, Mafficini A, Rieber N, Le Corre D, Rachiglio AM, Reiman A, Sheils O, Noppen C, Lacroix L, Cree IA, Scarpa A, Ligtenberg MJ, Laurent-Puig P (2015) Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium. BMC Cancer 15(1):26. https://doi.org/10.1186/s12885-015-1015-5 CrossRefPubMedPubMedCentral

28.

Tsongalis GJ, Peterson JD, de Abreu FB, Tunkey CD, Gallagher TL, Strausbaugh LD, Wells WA, Amos CI (2014) Routine use of the Ion Torrent AmpliSeq Cancer Hotspot Panel for identification of clinically actionable somatic mutations. Clinical chemistry and laboratory medicine : CCLM / FESCC 52(5):707–714. https://doi.org/10.1515/cclm-2013-0883 CrossRef

29.

Weissbach S, Langer C, Puppe B, Nedeva T, Bach E, Kull M, Bargou R, Einsele H, Rosenwald A, Knop S, Leich E (2015) The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma. Br J Haematol 169(1):57–70. https://doi.org/10.1111/bjh.13256 CrossRefPubMed

Title: Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics
Authors: B. Hirsch
V. Endris
S. Lassmann
W. Weichert
N. Pfarr
P. Schirmacher
V. Kovaleva
M. Werner
I. Bonzheim
F. Fend
J. Sperveslage
K. Kaulich
A. Zacher
G. Reifenberger
K. Köhrer
S. Stepanow
S. Lerke
T. Mayr
D. E. Aust
G. Baretton
S. Weidner
A. Jung
T. Kirchner
M. L. Hansmann
L. Burbat
E. von der Wall
M. Dietel
M. Hummel
Publication date: 01-04-2018
Publisher: Springer Berlin Heidelberg
Published in: Virchows Archiv / Issue 4/2018
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-017-2288-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast

Book Review—Pulmonary Pathology, 2nd Edition

CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases

Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why?

Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung